[HTML][HTML] Phosphorylated tau in Alzheimer's disease and other tauopathies

P Rawat, U Sehar, J Bisht, A Selman… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …

[HTML][HTML] Insulin and insulin resistance in Alzheimer's disease

A Sędzikowska, L Szablewski - International journal of molecular sciences, 2021 - mdpi.com
Insulin plays a range of roles as an anabolic hormone in peripheral tissues. It regulates
glucose metabolism, stimulates glucose transport into cells and suppresses hepatic glucose …

Cryo-EM structures of tau filaments

SHW Scheres, W Zhang, B Falcon… - Current Opinion in …, 2020 - Elsevier
Highlights•Cryo-EM may be used to determine atomic structures of amyloid filaments
extracted from human brain tissue.•Unique protofilament folds characterise tau filaments …

[HTML][HTML] The neuroprotective potentiality of flavonoids on Alzheimer's disease

A Calderaro, GT Patanè, E Tellone, D Barreca… - International journal of …, 2022 - mdpi.com
Alzheimer's disease (AD), due to its spread, has become a global health priority, and is
characterized by senile dementia and progressive disability. The main cause of AD and …

[HTML][HTML] Friend or foe—Post-translational modifications as regulators of phase separation and RNP granule dynamics

M Hofweber, D Dormann - Journal of Biological Chemistry, 2019 - ASBMB
Ribonucleoprotein (RNP) granules are membrane-less organelles consisting of RNA-
binding proteins (RBPs) and RNA. RNA granules form through liquid–liquid phase …

[HTML][HTML] Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

C Laurent, L Buée, D Blum - Biomedical journal, 2018 - Elsevier
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common
type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD …

[HTML][HTML] Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient …

NR Barthélemy, RJ Bateman, C Hirtz, P Marin… - Alzheimer's research & …, 2020 - Springer
Background Cerebrospinal fluid biomarker profiles characterized by decreased amyloid-
beta peptide levels and increased total and phosphorylated tau levels at threonine 181 …

Tau imaging: early progress and future directions

VL Villemagne, MT Fodero-Tavoletti… - The Lancet …, 2015 - thelancet.com
Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation
in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies …

[HTML][HTML] GSK-3β, a pivotal kinase in Alzheimer disease

M Llorens-Marítin, J Jurado, F Hernández… - Frontiers in molecular …, 2014 - frontiersin.org
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

EM Mandelkow, E Mandelkow - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD),
the neurofibrillary tangles, and is therefore of major interest as an indicator of disease …